Published By
Created On
16 Mar 2024 10:23:58 UTC
Transaction ID
Cost
Safe for Work
Free
Yes
Innovating Healthcare Faster for All - Dr. Omid Veiseh & Dr. Paul Wotton - Rice Biotech Launchpad
Dr. Omid Veiseh, Ph.D. ( https://profiles.rice.edu/faculty/omid-veiseh ) is Associate Professor in the Department of Bioengineering, CPRIT Scholar in Cancer Research and Director of the Biotech Launch Pad at Rice University ( https://biotechlaunchpad.rice.edu/ ), where he leads a research program aimed at engineering next-generation treatments for a wide range of human diseases by leveraging the latest techniques in synthetic biology, immuno-engineering, and materials science to develop innovative cell-based platforms for real-time production of biologics. He is also a serial entrepreneur who has co-founded Sigilon Therapeutics (Nasdaq:SGTX), Avenge Bio, Sentinel Bio, and Curada Bio. These companies collectively have attracted ~ US$500M in private and public investment capital.
Dr. Veiseh received a dual Ph. D. in Materials Science & Engineering and Nanotechnology from the University of Washington. He completed his postdoctoral research with Prof. Robert Langer and Daniel G. Anderson at MIT and Harvard Medical School. Throughout his career, he has authored or co-authored more than 75 peer-reviewed publications, including those in Nature, Nature Biotechnology, Nature Materials, Nature Medicine, and Natural Biomedical Engineering. He is an inventor of more than 40 pending or awarded patents.
Dr. Paul Wotton, Ph.D. ( https://biotechlaunchpad.rice.edu/paul-w ) is Rice Biotech Launchpad, Executive Director.
Dr. Wotton received his Ph.D. in Pharmaceutical Sciences from the University of Nottingham and is an experienced CEO, Board Member, named inventor and entrepreneur. He has extensive experience in strategic growth management, business transactions and product development. Dr. Wotton serves on the Board of Directors of Vericel Corporation (NASDAQ: VCEL), Cynata Therapeutics (ASX: CYP), Kytopen (Chairman), Combined Therapeutics and is a Co-Founder and Director of Avenge Bio., a clinical stage biotechnology company. Dr. Wotton was President and CEO of Ocata Therapeutics (NASDAQ:OCAT) until its acquisition by Astellas Pharma in 2016. Paul was named as a “Top 100 Innovation CEO” by World Biz Magazine and won the Ernst & Young Entrepreneur of the Year Regional (NJ) Life Sciences award in 2014.
...
https://www.youtube.com/watch?v=jEsWA9Fj5mA
Dr. Veiseh received a dual Ph. D. in Materials Science & Engineering and Nanotechnology from the University of Washington. He completed his postdoctoral research with Prof. Robert Langer and Daniel G. Anderson at MIT and Harvard Medical School. Throughout his career, he has authored or co-authored more than 75 peer-reviewed publications, including those in Nature, Nature Biotechnology, Nature Materials, Nature Medicine, and Natural Biomedical Engineering. He is an inventor of more than 40 pending or awarded patents.
Dr. Paul Wotton, Ph.D. ( https://biotechlaunchpad.rice.edu/paul-w ) is Rice Biotech Launchpad, Executive Director.
Dr. Wotton received his Ph.D. in Pharmaceutical Sciences from the University of Nottingham and is an experienced CEO, Board Member, named inventor and entrepreneur. He has extensive experience in strategic growth management, business transactions and product development. Dr. Wotton serves on the Board of Directors of Vericel Corporation (NASDAQ: VCEL), Cynata Therapeutics (ASX: CYP), Kytopen (Chairman), Combined Therapeutics and is a Co-Founder and Director of Avenge Bio., a clinical stage biotechnology company. Dr. Wotton was President and CEO of Ocata Therapeutics (NASDAQ:OCAT) until its acquisition by Astellas Pharma in 2016. Paul was named as a “Top 100 Innovation CEO” by World Biz Magazine and won the Ernst & Young Entrepreneur of the Year Regional (NJ) Life Sciences award in 2014.
...
https://www.youtube.com/watch?v=jEsWA9Fj5mA
Author
Content Type
Unspecified
video/mp4
Language
English
More from the publisher
Controlling
VIDEO
DR RE
dr-renée-deehan-vp,-science-ai,
Dr. Renée Deehan, Ph.D. is the VP of Science & Artificial Intelligence at InsideTracker ( https://www.insidetracker.com/ ), and leads a science team that builds and mines the world's largest data set of blood, DNA, fitness tracking and phenotypic data from healthy people, creating evidence-based solutions that are simple, clear, and actionable.
Dr. Deehan has spent her career working in the precision medicine and personalized nutrition domains, previously serving as the VP of Computational Biology & Translational Informatics at QuartzBio and as the VP of Biology and Bioinformatics at PatientsLikeMe, the world’s largest integrated community, health management, and real-world data platform.
At PatientsLikeMe, Dr. Deehan was responsible for data and knowledge engineering, AI/machine-learning, and translational biology functions that drove infrastructure and consumer & business product development. She was also the Principal Investigator for the DigitalMe Ignite program, which collected longitudinal blood and patient-generated health data from over 5,000 at-home site visits from over 2,000 participants and was able to generate over 2 Million data points from the DigitalMe program.
Dr. Deehan also designed and cross-functionally implemented the first generation of an “advanced research platform”, capable of integrating survey and omics data for biomarker analysis, including ensemble-based machine-learning pipelines. Additionally, they developed an outsourced pipeline to support their wet-lab omics needs (DNA/RNAseq, proteomics, immune sequencing/antibody repertoire analysis, metabolomics, methylomics).
Dr. Deehan has a Ph.D in Molecular and Cell Biology from University of California, Berkeley and a BSE in Bioengineering from University of Pennsylvania.
Dr. Deehan LinkedIn - https://www.linkedin.com/in/ren%C3%A9e-deehan-747b471/
...
https://www.youtube.com/watch?v=QCphi0OvD3I
Transaction
Created
1 year ago
Content Type
Language
video/mp4
English
Controlling
VIDEO
DR NI
dr-nicole-prause-advancing-research-in
Dr. Nicole Prause, PhD is an American neuroscientist researching human sexual behavior, addiction, and the physiology of sexual response. She is also the founder of Liberos LLC, an independent research institute and biotechnology company.
Dr. Prause obtained her doctorate in 2007 at Indiana University Bloomington, with joint supervision by the Kinsey Institute for Research in Sex, Gender, and Reproduction, with her areas of concentration being neuroscience and statistics. Her clinical internship, in neuro-psychological assessment and behavioral medicine, was with the VA Boston Healthcare System's Psychology Internship Training Program. Her research fellowship was in couples' treatment of alcoholism was at Harvard University.
Dr. Prause became a tenure track faculty member at Idaho State University at the age of 29. After three years there, she accepted a position as a Research Scientist at the Mind Research Network, a neuro-imaging facility in Albuquerque, New Mexico.
In 2012, Dr. Prause was elected a full member of the International Academy of Sex Research and accepted a position as a Research Scientist on faculty at the University of California, Los Angeles in the David Geffen School of Medicine. While there, she was promoted to Associate Research Scientist in 2014.
Dr. Prause founded Liberos LLC in 2015 and she continues to practice as licensed psychologist in California.
...
https://www.youtube.com/watch?v=rFiehQLjPpk
Transaction
Created
1 year ago
Content Type
Language
video/mp4
English
Controlling
VIDEO
DR #D
dr-deanradin,-phd-chiefscientist,
Short from @Progress, Potential, and Possibilities - https://www.youtube.com/watch?v=vV-MUjRWWOk
...
https://www.youtube.com/watch?v=ilVxGArhePc
Transaction
Created
1 year ago
Content Type
Language
video/mp4
English
Controlling
VIDEO
#DAVE
daveasprey-father-of-biohacking
Short from @Progress, Potential, and Possibilities - https://www.youtube.com/watch?v=lMIWf6CDZPA&t=1s
...
https://www.youtube.com/watch?v=2MFfWVNNi0g
Transaction
Created
1 year ago
Content Type
Language
video/mp4
English
Controlling
VIDEO
DR. S
dr.-syra-madad-senior-director,-system
Dr. Syra Madad, DHSc, MSc, MCP is the Senior Director of the System-wide Special Pathogens Program, and Co-Principal Investigator at the Institute of Disaster and Disaster Management, at NYC Health + Hospitals ( https://www.nychealthandhospitals.org/institute-for-disease-and-disaster-management/the-team/ ). Her work focuses on the preparedness for, response to and recovery from infectious disease outbreaks with an emphasis on healthcare and public health biopreparedness.
Dr. Madad built NYC Health + Hospitals special pathogens program from the ground up, maintaining readiness for the nation’s largest municipal healthcare delivery system for all infectious disease threats through ongoing training, education, drills, developing protocols, and processes and more. She’s responded to multiple infectious disease outbreaks as an infectious disease epidemiologist including Ebola, Measles and Zika.
In addition, Dr. Madad is a fellow at the Harvard Kennedy School Belfer Center for Science and International Affairs ( https://www.belfercenter.org/person/syra-madad ) where she regularly publishes on the latest public health guidance, epidemiological concepts and scientific literature to help the public understand complex topics using infographics and simplified science communication. She was prominently featured in the Netflix docuseries, Pandemic: How to Prevent an Outbreak ( https://www.netflix.com/title/81026143 ), and the Discovery Channel documentary, The Vaccine: Conquering COVID ( https://go.discovery.com/tv-shows/the-vaccine-conquering-covid/full-episodes/the-vaccine-conquering-covid ).
Dr. Madad received a B.S. in Psychology and a master's degree in Biotechnology with a concentration in Biodefense and Biosecurity, from the University of Maryland, College Park and then received an DHSc degree in health science with a concentration in Global Health from Nova Southeastern University. She holds numerous professional certifications, licenses and training certificates including Master Continuity Practitioner Certification (FEMA), Advanced Emergency Planning Certification, All Hazard Response (CBRNE) Training for Laboratory Personnel, Infection Control and Prevention Certification, Biosafety Level III Training, and Identification of the Primary Select Agents of Bioterrorism Training.
...
https://www.youtube.com/watch?v=CwcAPNTngGE
Transaction
Created
5 months ago
Content Type
Language
video/mp4
English
Controlling
VIDEO
KAZUH
kazuhiro-gomi-dr.-joe-alexander-bio
Mr. Kazuhiro Gomi, is President and CEO of NTT Research (https://ntt-research.com/), a division of The Nippon Telegraph and Telephone Corporation, commonly known as NTT (https://www.global.ntt/), a Japanese telecommunications company headquartered in Tokyo, Japan. Mr. Gomi has been at NTT for more than 30 years and was involved in product management/product development activities at the beginning of his tenure. In September of 2009, Mr. Gomi was first named to the Global Telecoms Business Power100 — a list of the 100 most powerful and influential people in the telecoms industry. He was the CEO of NTT America Inc. from 2010 to 2019 and also served on the Board of Directors at NTT Communications from 2012 to 2019. Mr. Gomi received a Masters of Science in Industrial Engineering from the University of Illinois at Urbana-Champaign, and a Master of Science in Electrical Engineering from Keio University, Tokyo. Mr. Gomi is a member of the board at US Japan Council, a non-profit organization aimed at fostering a better relationship between the US and Japan.
Dr. Joe Alexander, is Director of the Medical and Health Informatics (MEI) Lab at NTT Research, where he oversees the MEI Lab research in multi-scale Precision Cardiology platforms such as the cardiovascular bio-digital twin, as well as heart-on-a-chip technology, specifically aimed at developing the infrastructure for a digital replica of an individual’s heart. In addition, the MEI Lab is working on nano- and micro-scale sensors and electrodes, other organ-on-a-chip micro-fluidics technologies, as well as wearable and remote sensing to support future bio-digital twin applications.
Before coming to NTT Research, Dr. Alexander spent 18 years at Pfizer, Inc., where he had most recently served as Senior Medical Director, Global Medical Affairs, working in cardiovascular medicine, worldwide clinical imaging and measurement technologies, medical devices and pulmonary hypertension, and regularly conducting modeling and simulation research in many of these areas. He previously worked for two years at Merck, Inc. and spent eight years at Vanderbilt University, where he completed a two-year residency in internal medicine and served as a professor of medicine and biomedical engineering. Dr. Alexander obtained his M.D. and Ph.D. (in biomedical engineering) degrees at the Johns Hopkins University School of Medicine.
...
https://www.youtube.com/watch?v=UeZk19icbHE
Transaction
Created
1 year ago
Content Type
Language
video/mp4
English
Controlling
VIDEO
MICHA
michael-lahiff-ceo,-zeroeyes-a.i.-gun
Michael (Mike) D. Lahiff serves as Chairman and Chief Executive Officer of ZeroEyes ( https://zeroeyes.com/ ), an intelligent video analytics company that uses artificial intelligence with existing security cameras to detect weapons and send alerts to local staff and first responders.
ZeroEyes delivers a proactive, human-verified A.I. gun detection solution that integrates into existing security cameras to stop mass shootings and gun-related violence; by reducing response times, providing actionable intelligence, and delivering clarity – ultimately saving lives. The company is the only AI-based gun detection video analytics platform with US Department of Homeland Security SAFETY Act Designation.
Prior to founding ZeroEyes, Mr. Lahiff served as Director of Digital Programs at Comcast NBC Universal where he oversaw the coordination between project management teams and software development teams in order to deliver multiple digital products. Prior to joining Comcast, Mr. Lahiff was the managing member of Horsemen Partners, a private fund focused on acquisitions of small and medium sized businesses.
Mr. Lahiff also spent ten years in the United States Navy, six of which were as a Navy SEAL. During service, he received 18 medals including the Navy/Marine Corps Achievement Medal, Navy Good Conduct Medal, Global War on Terrorism Medal, National Defense Service Medal, NATO Medal, and Global War on Terrorism Service Medal.
Mr. Lahiff holds a Bachelor of Science degree in Business Administration and Finance from Columbia College and a Master of Business Administration in Private Equity & Venture Capital from the Wharton School at the University of Pennsylvania.
...
https://www.youtube.com/watch?v=FEHDJ3aPJQc
Transaction
Created
1 year ago
Content Type
Language
video/mp4
English
Controlling
VIDEO
DR. #
dr.-peterhotez-talking-about
Short from @Progress, Potential, and Possibilities - https://www.youtube.com/watch?v=KrrsoGFlt_o&t=1s
...
https://www.youtube.com/watch?v=xyM-5szA25M
Transaction
Created
1 year ago
Content Type
Language
video/mp4
English
Controlling
VIDEO
DR. #
dr.-christofkoch-discussing-neardeath
Short from @Progress, Potential, and Possibilities - https://www.youtube.com/watch?v=9j7qvDBykjc
...
https://www.youtube.com/watch?v=OdJsgCwLAqI
Transaction
Created
1 year ago
Content Type
Language
video/mp4
English